ORIGINAL RESEARCH article
Front. Cell. Neurosci., 04 March 2019
Sec. Cellular Neuropathology
Volume 13 - 2019 | https://doi.org/10.3389/fncel.2019.00061
RETRACTED: Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro
- LC
Lei Chen 1†
- YL
Yue-cheng Liu 2†
- HT
Hui Tan 1
- YZ
Yuan Zhang 1
- JX
Ji Xu 1
- WL
Wen-lan Liu 1
- ZL
Zong-yang Li 1*
- WL
Wei-ping Li 1*
1. Shenzhen Key Laboratory of Neurosurgery, Brain Center, Shenzhen Second People’s Hospital, Shenzhen University 1st Affiliated Hospital, Shenzhen, China
2. Guangzhou Medical University, Guangzhou, China
Summary
Citation
Chen L, Liu Y, Tan H, Zhang Y, Xu J, Liu W, Li Z and Li W (2019) RETRACTED: Santacruzamate A Ameliorates AD-Like Pathology by Enhancing ER Stress Tolerance Through Regulating the Functions of KDELR and Mia40-ALR in vivo and in vitro. Front. Cell. Neurosci. 13:61. doi: 10.3389/fncel.2019.00061
Received
09 October 2018
Accepted
06 February 2019
Published
04 March 2019
Volume
13 - 2019
Edited by
Stefania Ceruti, University of Milan, Italy
Reviewed by
Ana María Sanchez-Perez, University of Jaume I, Spain; Julie Atkin, Macquarie University, Australia
Updates
†These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.